OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation
Ahmed E. Azab, Mohamed S. Alesawy, Wagdy M. Eldehna, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Closed Access | Times Cited: 10
Ahmed E. Azab, Mohamed S. Alesawy, Wagdy M. Eldehna, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Closed Access | Times Cited: 10
Showing 10 citing articles:
Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies
Mahfam Moradi, Ali Mousavi, Zahra Emamgholipour, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115626-115626
Closed Access | Times Cited: 31
Mahfam Moradi, Ali Mousavi, Zahra Emamgholipour, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115626-115626
Closed Access | Times Cited: 31
A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-b]quinoxaline derivatives hybrid with a sulfonamide moiety
Mostafa A. Ismail, Moustafa S. Abusaif, M. S. A. El‐Gaby, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12589-12608
Open Access | Times Cited: 25
Mostafa A. Ismail, Moustafa S. Abusaif, M. S. A. El‐Gaby, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12589-12608
Open Access | Times Cited: 25
Evaluation of the anti-proliferative activity of 2-oxo-pyridine and 1′H-spiro-pyridine derivatives as a new class of EGFRWt and VEGFR-2 inhibitors with apoptotic inducers
Reham R. Raslan, Yousry A. Ammar, Sawsan A. Fouad, et al.
RSC Advances (2023) Vol. 13, Iss. 15, pp. 10440-10458
Open Access | Times Cited: 24
Reham R. Raslan, Yousry A. Ammar, Sawsan A. Fouad, et al.
RSC Advances (2023) Vol. 13, Iss. 15, pp. 10440-10458
Open Access | Times Cited: 24
Synthesis, Characterization, Antibacterial, Antifungal and Anticorrosion Activities of 1,2,4-Triazolo[1,5-a]quinazolinone
Walid Ettahiri, Rajae Salim, Mohamed Adardour, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5340-5340
Open Access | Times Cited: 24
Walid Ettahiri, Rajae Salim, Mohamed Adardour, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5340-5340
Open Access | Times Cited: 24
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 12
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 12
Identification of 2-(N-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity
Ahmed Sabt, Maha-Hamadien Abdulla, Manal S. Ebaid, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 9
Ahmed Sabt, Maha-Hamadien Abdulla, Manal S. Ebaid, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 9
Quinazolines annelated at the N(3)–C(4) bond: Synthesis and biological activity
Emiliya V. Nosova, G. N. Lipunova, Yulia V. Permyakova, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116411-116411
Closed Access | Times Cited: 6
Emiliya V. Nosova, G. N. Lipunova, Yulia V. Permyakova, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116411-116411
Closed Access | Times Cited: 6
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and in silico studies
Reda R. Mabrouk, Hazem A. Mahdy, Abdallah E. Abdallah, et al.
Future Medicinal Chemistry (2025), pp. 1-13
Closed Access
Reda R. Mabrouk, Hazem A. Mahdy, Abdallah E. Abdallah, et al.
Future Medicinal Chemistry (2025), pp. 1-13
Closed Access
New vatalanib analogs: design, synthesis, in silico study and biological evaluation for anticancer activity
Abdallah E. Abdallah, Hazem Elkady, Alaa Elwan, et al.
Journal of Molecular Structure (2024) Vol. 1322, pp. 140595-140595
Closed Access | Times Cited: 2
Abdallah E. Abdallah, Hazem Elkady, Alaa Elwan, et al.
Journal of Molecular Structure (2024) Vol. 1322, pp. 140595-140595
Closed Access | Times Cited: 2
Triazoloquinazoline: Synthetic Strategies and Medicinal Importance
Tooba Jabeen, Sana Aslam, Matloob Ahmad, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 2
Tooba Jabeen, Sana Aslam, Matloob Ahmad, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 2
